Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - OREGON
['FUNDING_OTHER'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-11132564
This study is looking for ways to create safer birth control options that help prevent unintended pregnancies and are especially designed for women who are obese, so if you're interested in helping improve contraceptive choices, this could be a great opportunity for you!
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON HEALTH & SCIENCE UNIVERSITY (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-11132564 on ClinicalTrials.gov |
What this research studies
This research focuses on creating new contraceptive methods that effectively prevent unintended pregnancies while also minimizing the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) is dedicated to developing protocols and conducting clinical trials aimed at advancing contraceptive product development. By participating in this research, patients may contribute to the creation of safer and more effective contraceptive options tailored to their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive options unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have any medical conditions affecting contraceptive use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer contraceptive methods that are particularly beneficial for women with obesity or other medical conditions.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, indicating that this approach has the potential for success.
Where this research is happening
PORTLAND, UNITED STATES
- OREGON HEALTH & SCIENCE UNIVERSITY — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: EDLMAN, ALISON — OREGON HEALTH & SCIENCE UNIVERSITY
- Study coordinator: EDLMAN, ALISON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.